BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16460337)

  • 1. Plasminogen activators and their inhibitors in human saliva and salivary gland tissue.
    Virtanen OJ; Sirén V; Multanen J; Färkkilä M; Leivo I; Vaheri A; Koskiniemi M
    Eur J Oral Sci; 2006 Feb; 114(1):22-6. PubMed ID: 16460337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
    Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
    Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas.
    Sirén V; Peltonen J; Vaheri A
    Arch Dermatol Res; 2006 Mar; 297(9):421-4. PubMed ID: 16408192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased release of tissue plasminogen activator and its inhibitor in human parotid saliva upon stimulation.
    Kjaeldgaard M; Lagerlöf F; Johansson I; Gaffney PJ; Kjaeldgaard A
    Acta Physiol Scand; 1992 Jul; 145(3):287-93. PubMed ID: 1381546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
    Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues.
    Span PN; Witjes JA; Grebenchtchikov N; Geurts-Moespot A; Moonen PM; Aalders TW; Vriesema JL; Kiemeney LA; Schalken JA; Sweep FC
    BJU Int; 2008 Jul; 102(2):177-82. PubMed ID: 18336603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
    Brown JM; Watanabe K; Cohen RL; Chambers DA
    Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
    Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
    Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spitz naevi may express components of the plasminogen activation system.
    Ferrier CM; Van Geloof WL; Straatman H; Van De Molengraft FJ; Van Muijen GN; Ruiter DJ
    J Pathol; 2002 Sep; 198(1):92-9. PubMed ID: 12210068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell line.
    George F; Pourreau-Schneider N; Arnoux D; Boutière B; Dussault N; Roux-Dosseto M; Alessi MC; Martin PM; Sampol J
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):689-93. PubMed ID: 2133249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma.
    España F; Estellés A; Fernández PJ; Gilabert J; Sánchez-Cuenca J; Griffin JH
    Thromb Haemost; 1993 Dec; 70(6):989-94. PubMed ID: 8165623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
    Padró T; Emeis JJ; Steins M; Schmid KW; Kienast J
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):893-902. PubMed ID: 7600121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
    Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A
    Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay.
    Rånby M; Nguyen G; Scarabin PY; Samama M
    Thromb Haemost; 1989 Jun; 61(3):409-14. PubMed ID: 2508254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.